NRX Pharmaceuticals (NRXP) Earnings Date & Reports

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXP is expected to report earnings to fall 85.29% to -5 cents per share on May 14

NRX Pharmaceuticals NRXP Stock Earnings Reports

Q1'24

Est.

$-0.05

Q1'25

Beat

by $0.19

Q4'24

Missed

by $0.66

Q4'23

Missed

by $0.43

Q3'23

Beat

by $0.04

The last earnings report on May 15 showed earnings per share of -34 cents, beating the estimate of -52 cents. With 259.89K shares outstanding, the current market capitalization sits at 66.70M.

View a ticker or compare two or three

Compare

NRXP